These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22228328)

  • 41. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
    Zuckerman SL; Bilsky MH; Laufer I
    World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive Value of Preoperative Magnetic Resonance Imaging Findings for Survival and Local Recurrence in Patients Undergoing En Bloc Resection of Sacral Chordomas.
    Zuckerman SL; Amini B; Lee SH; Rao G; Tatsui CE; Rhines LD
    Neurosurgery; 2019 Dec; 85(6):834-842. PubMed ID: 30541143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of the BMP4/SMAD signaling pathway in skull base chordomas is associated with poor prognosis.
    Feng Y; Zhang Q; Wang Z; Yan B; Wei W; Li P
    Int J Clin Exp Pathol; 2015; 8(7):8268-75. PubMed ID: 26339396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy.
    Holliday EB; Mitra HS; Somerson JS; Rhines LD; Mahajan A; Brown PD; Grosshans DR
    Spine (Phila Pa 1976); 2015 Apr; 40(8):544-9. PubMed ID: 25627289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma.
    Naka T; Boltze C; Kuester D; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Am J Clin Pathol; 2004 Dec; 122(6):926-30. PubMed ID: 15539385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.
    Chen YL; Liebsch N; Kobayashi W; Goldberg S; Kirsch D; Calkins G; Childs S; Schwab J; Hornicek F; DeLaney T
    Spine (Phila Pa 1976); 2013 Jul; 38(15):E930-6. PubMed ID: 23609202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases.
    Hoch BL; Nielsen GP; Liebsch NJ; Rosenberg AE
    Am J Surg Pathol; 2006 Jul; 30(7):811-8. PubMed ID: 16819322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome.
    de Castro CV; Guimaraes G; Aguiar S; Lopes A; Baiocchi G; da Cunha IW; Campos AH; Soares FA; Begnami MD
    Hum Pathol; 2013 Sep; 44(9):1747-55. PubMed ID: 23618355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.
    Castellano I; Allia E; Accortanzo V; Vandone AM; Chiusa L; Arisio R; Durando A; Donadio M; Bussolati G; Coates AS; Viale G; Sapino A
    Breast Cancer Res Treat; 2010 Dec; 124(3):607-17. PubMed ID: 20127405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors influencing the survival of patients with skull base chordoma].
    Zhang JT; Wang L; Wu Z; Jia GJ; Zhang LW
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1607-10. PubMed ID: 17803849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine.
    Potluri S; Jefferies SJ; Jena R; Harris F; Burton KE; Prevost AT; Burnet NG
    Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):199-208. PubMed ID: 20980136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
    Lee IJ; Lee RJ; Fahim DK
    World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.